EV/EBITDA:
13.30-0.55(-3.97%)Summary
- As of today (September 16, 2025), SUPN EV/EBITDA is 13.30, with a fall of -0.55 (-3.97%) during the most recent trading session on September 15, 2025.
- Over the past year, SUPN EV/EBITDA has increased by +2.10 (+18.75%).
- SUPN EV/EBITDA is now -73.83% below its all-time high of 50.83.
Performance
SUPN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SUPN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -4.0% | -4.0% | -3.2% |
| 1 m1 month | +3.8% | +3.8% | +3.0% |
| 3 m3 months | +51.3% | +45.1% | +37.3% |
| 6 m6 months | +54.3% | +49.1% | +40.7% |
| ytdytd | +28.1% | +23.8% | +21.6% |
| 1 y1 year | +18.8% | +40.4% | +41.4% |
| 5 y5 years | +92.2% | +63.0% | +100.3% |
SUPN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | 14.31 | -7.1% | 12.55 | +6.0% |
| 3 m | 3-month | 14.31 | -7.1% | 8.47 | +57.0% |
| 6 m | 6-month | 14.31 | -7.1% | 8.16 | +63.0% |
| 1 y | 1-year | 14.31 | -7.1% | 8.16 | +63.0% |
| 3 y | 3-year | 19.33 | -31.2% | 8.16 | +63.0% |
| 5 y | 5-year | 19.33 | -31.2% | 5.15 | +158.3% |
| alltime | all time | 50.83 | -73.8% | -13.01 | +202.2% |
SUPN EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 13.30(+28.1%) |
| 2024 | 10.38(-25.6%) |
| 2023 | 13.95(-4.3%) |
| 2022 | 14.57(+18.8%) |
| 2021 | 12.26(+89.2%) |
| 2020 | 6.48(-29.8%) |
| 2019 | 9.23(-26.4%) |
| Date | Value |
|---|---|
| 2018 | 12.54(-31.5%) |
| 2017 | 18.31(-15.7%) |
| 2016 | 21.73(-31.2%) |
| 2015 | 31.58(+128.8%) |
| 2014 | 13.80(-378.8%) |
| 2013 | -4.95(+1.2%) |
| 2012 | -4.89 |
FAQ
- What is Supernus Pharmaceuticals, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Supernus Pharmaceuticals, Inc.?
- What is SUPN EV/EBITDA year-to-date change?
- What is Supernus Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Supernus Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of SUPN is 13.30
What is the all time high EV/EBITDA for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high EV/EBITDA is 50.83
What is SUPN EV/EBITDA year-to-date change?
Supernus Pharmaceuticals, Inc. EV/EBITDA has changed by +2.92 (+28.13%) since the beginning of the year
What is Supernus Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, SUPN EV/EBITDA has changed by +2.10 (+18.75%)